• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Ion channels, transporters, and pumps as targets for heart failure therapy.离子通道、转运体和泵作为心力衰竭治疗的靶点。
J Cardiovasc Pharmacol. 2009 Oct;54(4):273-8. doi: 10.1097/FJC.0b013e3181a1b9c7.
2
Marine omega-3 highly unsaturated fatty acids: From mechanisms to clinical implications in heart failure and arrhythmias.海洋ω-3高度不饱和脂肪酸:从机制到心力衰竭和心律失常的临床意义
Vascul Pharmacol. 2016 Jul;82:11-9. doi: 10.1016/j.vph.2016.03.007. Epub 2016 Apr 11.
3
Ion channels as novel therapeutic targets in heart failure.离子通道作为心力衰竭的新型治疗靶点。
Ann Med. 2005;37(1):44-54. doi: 10.1080/07853890510007214.
4
Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation.心脏中致心律失常的离子通道重塑:心力衰竭、心肌梗死与心房颤动
Physiol Rev. 2007 Apr;87(2):425-56. doi: 10.1152/physrev.00014.2006.
5
Arrhythmogenic Remodeling in the Failing Heart.心律失常性重构在心力衰竭中的作用。
Cells. 2021 Nov 17;10(11):3203. doi: 10.3390/cells10113203.
6
Mechanistic Relevance of Ventricular Arrhythmias in Heart Failure with Preserved Ejection Fraction.射血分数保留的心力衰竭中心律失常的机制相关性
Int J Mol Sci. 2024 Dec 14;25(24):13423. doi: 10.3390/ijms252413423.
7
Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure.抑制 N 型钙通道可改善心力衰竭小鼠心脏自主神经活动失衡,并预防致死性心律失常。
Cardiovasc Res. 2014 Oct 1;104(1):183-93. doi: 10.1093/cvr/cvu185. Epub 2014 Aug 5.
8
Remodelling of cardiac repolarization: how homeostatic responses can lead to arrhythmogenesis.心脏复极化重塑:稳态反应如何导致心律失常的发生。
Cardiovasc Res. 2009 Feb 15;81(3):491-9. doi: 10.1093/cvr/cvn266. Epub 2008 Sep 30.
9
Ryanodine receptor 2 inhibition reduces dispersion of cardiac repolarization, improves contractile function, and prevents sudden arrhythmic death in failing hearts.ryanodine 受体 2 抑制可减少心脏复极的离散度,改善收缩功能,并预防衰竭心脏中的心律失常性猝死。
Elife. 2023 Dec 11;12:RP88638. doi: 10.7554/eLife.88638.
10
[Antiarrhythmic therapy in patients with heart failure].心力衰竭患者的抗心律失常治疗
Ther Umsch. 2000 May;57(5):324-32. doi: 10.1024/0040-5930.57.5.324.

引用本文的文献

1
Proanthocyanidins Maintain Cardiac Ionic Homeostasis in Aldosterone-Induced Hypertension and Heart Failure.原花青素在醛固酮诱导的高血压和心力衰竭中维持心脏离子稳态。
Int J Mol Sci. 2021 Sep 4;22(17):9602. doi: 10.3390/ijms22179602.
2
Ischemic Heart Disease and Heart Failure: Role of Coronary Ion Channels.缺血性心脏病和心力衰竭:冠状动脉离子通道的作用。
Int J Mol Sci. 2020 Apr 30;21(9):3167. doi: 10.3390/ijms21093167.
3
Ranolazine: A true pluripotent cardiovascular drug or jack of all trades, master of none?雷诺嗪:一种真正具有多效性的心血管药物,还是样样皆通却无一精通?
Sultan Qaboos Univ Med J. 2018 Feb;18(1):e13-e23. doi: 10.18295/squmj.2018.18.01.003. Epub 2018 Apr 4.
4
ProBLM web server: protein and membrane placement and orientation package.ProBLM网络服务器:蛋白质和膜的定位与定向软件包。
Comput Math Methods Med. 2014;2014:838259. doi: 10.1155/2014/838259. Epub 2014 Jul 14.
5
The cardiac L-type calcium channel distal carboxy terminus autoinhibition is regulated by calcium.心脏 L 型钙通道远端羧基末端自身抑制受钙调节。
Am J Physiol Heart Circ Physiol. 2013 Feb 1;304(3):H455-64. doi: 10.1152/ajpheart.00396.2012. Epub 2012 Nov 30.

本文引用的文献

1
Rescuing a failing heart: putting on the squeeze.拯救衰竭心脏:施以挤压之力。
Nat Med. 2009 Jan;15(1):24-5. doi: 10.1038/nm0109-24.
2
Rescue of Ca2+ overload-induced left ventricular dysfunction by targeted ablation of phospholamban.通过靶向消融受磷蛋白来挽救钙超载诱导的左心室功能障碍。
Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H310-7. doi: 10.1152/ajpheart.00975.2008. Epub 2008 Dec 12.
3
Sodium ion transporters as new therapeutic targets in heart failure.钠离子转运体作为心力衰竭的新治疗靶点
Cardiovasc Hematol Agents Med Chem. 2008 Oct;6(4):229-36. doi: 10.2174/187152508785909546.
4
Ranolazine combined with enalapril or metoprolol prevents progressive LV dysfunction and remodeling in dogs with moderate heart failure.雷诺嗪联合依那普利或美托洛尔可预防中度心力衰竭犬的左心室功能障碍和重塑进展。
Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H2149-55. doi: 10.1152/ajpheart.00728.2008. Epub 2008 Sep 26.
5
Prevention of ventricular arrhythmias with sarcoplasmic reticulum Ca2+ ATPase pump overexpression in a porcine model of ischemia reperfusion.在猪缺血再灌注模型中通过过表达肌浆网Ca2+ATP酶泵预防室性心律失常
Circulation. 2008 Aug 5;118(6):614-24. doi: 10.1161/CIRCULATIONAHA.108.770883. Epub 2008 Jul 21.
6
Gene therapy in heart failure.心力衰竭的基因治疗
Circ Res. 2008 Jun 20;102(12):1458-70. doi: 10.1161/CIRCRESAHA.108.173195.
7
Molecular identity of the late sodium current in adult dog cardiomyocytes identified by Nav1.5 antisense inhibition.通过Nav1.5反义抑制鉴定成年犬心肌细胞中晚钠电流的分子特性。
Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H667-76. doi: 10.1152/ajpheart.00111.2008. Epub 2008 Jun 13.
8
Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure.一项针对心力衰竭患者冠状动脉内注射AAV1/SERCA2a的1/2期试验设计。
J Card Fail. 2008 Jun;14(5):355-67. doi: 10.1016/j.cardfail.2008.02.005. Epub 2008 May 27.
9
Chronic inhibition of the Na+/H+ - exchanger causes regression of hypertrophy, heart failure, and ionic and electrophysiological remodelling.对钠氢交换体的长期抑制会导致心肌肥大消退、心力衰竭以及离子和电生理重塑。
Br J Pharmacol. 2008 Jul;154(6):1266-75. doi: 10.1038/bjp.2008.189. Epub 2008 May 19.
10
Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study.卡立泊来德抑制钠氢交换以降低冠状动脉搭桥术患者缺血性心脏事件风险:EXPEDITION研究结果
Ann Thorac Surg. 2008 Apr;85(4):1261-70. doi: 10.1016/j.athoracsur.2007.10.054.

离子通道、转运体和泵作为心力衰竭治疗的靶点。

Ion channels, transporters, and pumps as targets for heart failure therapy.

机构信息

Division of Cardiology, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.

出版信息

J Cardiovasc Pharmacol. 2009 Oct;54(4):273-8. doi: 10.1097/FJC.0b013e3181a1b9c7.

DOI:10.1097/FJC.0b013e3181a1b9c7
PMID:19365280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2766421/
Abstract

Congestive heart failure is a leading cause of morbidity and mortality. Congestive heart failure is marked by atrial and ventricular enlargements and reduced cardiac contractility and an association with an increased incidence of atrial and ventricular arrhythmias and sudden cardiac death. Dysfunctional ion channel function is one of the major underlying mechanisms of the reduced contractility and arrhythmias. In this review, we explore the utility of ion channels, transporters, and pumps as targets for the treatment of heart failure, focusing predominantly on the treatment for reduced contractility and arrhythmias.

摘要

充血性心力衰竭是发病率和死亡率的主要原因。充血性心力衰竭的特征是心房和心室增大,心肌收缩力降低,并与房性和室性心律失常以及心脏性猝死的发生率增加相关。离子通道功能障碍是收缩力降低和心律失常的主要潜在机制之一。在这篇综述中,我们探讨了离子通道、转运体和泵作为心力衰竭治疗靶点的应用,主要集中在治疗收缩力降低和心律失常方面。